MetaCap

China Pharma Earnings

NYSE: CPHIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4384-0.0655 (-13.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

China Pharma earnings summary

In its most recent report on Nov 18, 2026 (Sep/2026), CPHI posted EPS of $-0.17. Across the last 15 reports, CPHI shares moved an average of 10.6% (in either direction) in the first trading session after results, rising 7 times and falling 5 times.

Summary generated from market data by MetaCap's automated system. Methodology

CPHI earnings history

China Pharma reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 18, 2026—$-0.17——
Nov 11, 2026—$-0.17—-15.4%
Aug 14, 2026—$-0.04—-13.3%
May 15, 2026—$-0.04—-26.9%
Apr 1, 2026—$-0.04—+3.2%
Nov 12, 2025—$-0.17—+7.4%
Aug 14, 2025—$-0.16—+2.8%
May 14, 2025—$-0.24—0.0%
Mar 31, 2025—$-0.45—-36.4%
Nov 13, 2024—$-0.65—0.0%
Aug 14, 2024—$-0.89—+10.0%
Apr 1, 2024—$-0.72—+15.6%
Nov 13, 2023—$-0.29—+11.1%
Aug 14, 2023—$-0.35—0.0%
May 12, 2023—$-0.06—+6.7%
Mar 30, 2023—$-3.22—-10.3%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related